Genitourinary Cancers

Latest News

A manageable safety profile was observed across 2 expansion doses of the combination in urothelial cancer, consistent with known adverse effects of both drugs.
IDE397 Combo Displays Promising Activity in MTAP-Deletion Urothelial Cancer

September 9th 2025

A manageable safety profile was observed across 2 expansion doses of the combination in urothelial cancer, consistent with known adverse effects of both drugs.

Changes in FKSI-15 scores from baseline indicated more favorable HRQOL outcomes with the benmelstobart combo vs sunitinib in advanced ccRCC.
Benmelstobart Combo Elicits PFS Advantage in Untreated Advanced ccRCC

September 5th 2025

External validation will be assessed in cohort 2 of the AURORAX-0087A trial to improve recurrence detection for clear cell renal cell carcinoma.
Urine Glycosaminoglycan Scores Show High Sensitivity to Detect ccRCC

September 3rd 2025

Patients with muscle-invasive bladder cancer with a positive Signatera test displayed a significant improvement in disease-free and overall survival.
ctDNA Test is Predictive of Adjuvant Atezolizumab Benefit in MIBC

August 18th 2025

Adverse reactions in the phase 3 ENVISION trial were largely mild to moderate in severity, and serious reactions occurred in 12% of those with NMIBC.
Mitomycin Exhibits Durable Responses in Recurrent, Low-Grade NMIBC

August 7th 2025

Video Series
Video Interviews
Podcasts
A group of community and academic oncologists exchanged ideas on optimizing therapy across different prostate, kidney, and bladder cancer populations.
Experts discuss considerations for improving the care of patients with prostate, kidney, and bladder cancer in community-based practices at World GU 2025.
At World GU 2025, experts discussed forming treatment strategies for patients with variant histologies across prostate, bladder, and kidney cancer.
Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.
Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.
Latest CME Events & Activities

More News